N/A N=404 Working With Veterans Organizations to Improve Blood Pressure
Hypertension
Primary: Change in Systolic Blood Pressure — -3.48; -5.45 mm Hg — p=0.2417
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=133 Genetic and Biochemical Markers of Interferon-Induced Depression.
Depression
Primary: Phenotype and Genotype Based on Presence of Interferon Induced MDD. — 19; 114 participants — p=>0.05
N/A N=885 Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
Coronary Artery Disease (CAD)
Primary: The Sensitivity of Visipaque-enhanced Coronary Computed Tomography Angiography (CCTA) for Predicting Downstream Cardiovascular Events at Each Follow-up Period When…
Phase 4 N=459 Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Attention-deficit/Hyperactivity Disorder
Primary: Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8 — -13.4; -25.6; -23.5 units on a scale…
N/A N=19 Improving Quality of Life for Veterans Undergoing Interferon Treatment
Depression · Hepatitis C
Primary: BDI — 12.93; 12.29; 10.45; 16.67 units on a scale — p=<.05
N/A N=100 Vapocoolant (Pain Ease) Use for Venipuncture
Pain
Primary: Pain Scale on Numeric Rating Scale (NRS) ( 0 to 10) — 1.7; 4.7 units on a scale
N/A N=110 Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive
Male Circumcision
Primary: Time for Procedure — 9.0 Min
N/A N=29 Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment
Apnea, Sleep · Chronic Fatigue Syndrome
Primary: Change of Fatigue Symptom — 2.1; 0.2 units on a scale — p=0.0002
N/A N=50 Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Hepatic Encephalopathy · Cirrhosis · Portosystemic Encephalopathy
Primary: Number of Participants With an Improvement of 1 or More in HE Grade at 24 Hours — 21; 13 participants
Phase 2 N=56 CMC (Carpometacarpal) OA (Osteoarthritis) Thumb Splint Study
Osteoarthritis
Primary: Hand Function — 5.54; 2.69 units on a scale
N/A N=129 A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC
Contraception · Bleeding
Primary: Number of Bleeding and Spotting Days — 27.5; 32; 44 DAYS — p=.03
Phase 1 N=26 Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
Epilepsy
Primary: Motor Reaction Time (MRT) (ms): Change From Baseline at Each Time Point During Acute Dosing Phase — 4.1; 0.7; -10.8 miliseconds
N/A N=14 Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway
Asthma
Primary: Maximum Change From Baseline in Airway Blood Flow (Qaw) — -11.0; 14.1; 23.9; 25.5 change from baseline ( µl/min/ml) — p=< 0.001
Phase 2 N=167 Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) — -0.37; -0.89; -1.03; -1.04 percentage of glycosylated hemoglobin — p=<0.001
Phase 3 N=15 A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
General Anxiety Disorder, Social Anxiety Disorder
Primary: Hamilton Anxiety Scale — 10.9 units on a scale